Most Popular
-
1
Now is no time to add pressure on businesses: top executives
-
2
CJ CheilJedang to spur overseas growth with new Hungary, US plants
-
3
Blackpink's solo journeys: Complementary paths, not competition
-
4
Nationwide rail disruptions feared as union plans strike from Dec. 5
-
5
Seoul to host winter festival from Dec. 13
-
6
N. Korea, Russia court softer image: From animal diplomacy to tourism
-
7
Smugglers caught disguising 230 tons of Chinese black beans as diesel exhaust fluid
-
8
[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts
![[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050099_0.jpg&u=20241121172748)
-
9
Main opposition pushes to ease, not postpone, tax on crypto gains
-
10
Actor Song Joong-ki welcomes second child in Rome
![[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050099_0.jpg&u=20241121172748)
Boehringer Ingelheim terminates contract with Hanmi Pharma
By 정민경Published : Sept. 30, 2016 - 10:44
[DISCLOSURE] Hanmi Pharmaceutical (128940) said on Sept. 30 that the contract regarding its lung cancer treatment HM61713 with German pharmaceutical firm, Boehringer Ingelheim has been terminated.
The German company will be returning its license obtained in 2015, but Hanmi Pharma is not obligated to refund the contract fee worth US$65 million.
(theinvestor@heraldcorp.com)
The German company will be returning its license obtained in 2015, but Hanmi Pharma is not obligated to refund the contract fee worth US$65 million.
(theinvestor@heraldcorp.com)
![[Today’s K-pop] Babymonster logs 100m views with ‘Drip’ music video](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2024/11/22/20241122050051_0.jpg&u=20241122172213)